Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 1.000 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.516 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.507 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.506 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.503 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.502 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.496 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.494 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.488 | |
| 4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.487 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.483 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.480 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.480 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.479 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.478 | |
| 3clb | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.478 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
| 3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.477 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.476 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.474 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.474 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.473 | |
| 1dis | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.472 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.472 | |
| 1ai9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.471 | |
| 1dr2 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.471 | |
| 3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.469 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
| 4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.469 | |
| 2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
| 3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.468 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.467 | |
| 2h2q | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.467 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.466 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.466 | |
| 1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.465 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.465 | |
| 1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.464 | |
| 3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.464 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.463 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.463 | |
| 3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.463 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
| 3qls | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
| 2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.461 | |
| 3dxm | N24 | Actin-related protein 3 | / | 0.461 | |
| 3sp9 | IL2 | Peroxisome proliferator-activated receptor delta | / | 0.461 | |
| 3uku | C69 | Actin-related protein 3 | / | 0.461 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.461 | |
| 1dr3 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 3tm5 | SFG | Uncharacterized protein | / | 0.460 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
| 3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.459 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.459 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.459 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.458 | |
| 3inv | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.458 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.457 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.457 | |
| 1dra | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
| 3hbb | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.456 | |
| 3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 3aty | FMN | Prostaglandin F2a synthase | / | 0.455 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.455 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.455 | |
| 4kl9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
| 1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.454 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.454 | |
| 4xxv | NAD | 3-isopropylmalate dehydrogenase | / | 0.454 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 3atz | FMN | Prostaglandin F2a synthase | / | 0.453 | |
| 4a6n | FAD | TetX family tetracycline inactivation enzyme | / | 0.453 | |
| 1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.452 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.452 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
| 3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.452 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.452 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.452 | |
| 4dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
| 4g3e | 0WC | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.452 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.452 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.452 | |
| 1n4h | REA | Nuclear receptor ROR-beta | / | 0.451 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.451 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
| 4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.451 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.451 | |
| 1tdr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
| 4eub | COA | Succinyl-CoA:acetate CoA-transferase | / | 0.450 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.450 | |
| 5hi6 | MTX | Dihydrofolate reductase | / | 0.450 | |
| 1dds | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.449 | |
| 4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.449 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.449 | |
| 1pag | FMP | Antiviral protein I | 3.2.2.22 | 0.448 | |
| 1rx1 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.448 | |
| 3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4l03 | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.448 | |
| 1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 1dr5 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 1zem | NAD | Xylitol dehydrogenase | / | 0.447 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.447 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3id8 | MRK | Glucokinase | 2.7.1.2 | 0.447 | |
| 3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3t1t | GDP | Probable gliding protein mglA | / | 0.447 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.447 | |
| 4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.447 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.447 | |
| 1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.446 | |
| 2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.446 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
| 3och | 2MX | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.446 | |
| 4g47 | TZF | Mycocyclosin synthase | 1.14.21.9 | 0.446 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.445 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.445 | |
| 2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.445 | |
| 3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.445 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.444 | |
| 3ey9 | TDP | Pyruvate dehydrogenase [ubiquinone] | 1.2.5.1 | 0.444 | |
| 3hk1 | B64 | Fatty acid-binding protein, adipocyte | / | 0.444 | |
| 3qly | 55V | Uncharacterized protein | / | 0.444 | |
| 3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3zux | TCH | Transporter | / | 0.444 | |
| 4f7i | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.444 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.444 | |
| 1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
| 1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.443 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 1mvs | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 1rb3 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.443 | |
| 3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.443 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.443 | |
| 3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3r6x | X84 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3s1d | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.443 | |
| 3tea | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.443 | |
| 3unk | 0BY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4i5h | G17 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.443 | |
| 1dir | NAD | Dihydropteridine reductase | 1.5.1.34 | 0.442 | |
| 1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.442 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
| 3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.442 | |
| 3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
| 3tz3 | B36 | Acetyl-CoA carboxylase | / | 0.442 | |
| 4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.442 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.442 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.441 | |
| 1ddr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 3had | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.441 | |
| 3kxw | 1ZZ | Saframycin Mx1 synthetase B | / | 0.441 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.441 | |
| 3vas | ADN | Putative adenosine kinase | / | 0.441 | |
| 4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.441 | |
| 4c2x | NHW | Glycylpeptide N-tetradecanoyltransferase 2 | / | 0.441 | |
| 4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 5ecc | NAP | Dehydrofolate reductase type I | / | 0.441 | |
| 1j3j | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.440 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.440 | |
| 3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |